123 related articles for article (PubMed ID: 18642466)
21. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
Zaratti L; Senatore S; Franco E
Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
[TBL] [Abstract][Full Text] [Related]
22. Molecular virology and epidemiology of human papillomavirus and cervical cancer.
Palefsky JM; Holly EA
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):415-28. PubMed ID: 7655339
[No Abstract] [Full Text] [Related]
23. Human Papillomavirus-Related Cancers.
Li Y; Xu C
Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
[TBL] [Abstract][Full Text] [Related]
24. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.
Gillison ML; Castellsagué X; Chaturvedi A; Goodman MT; Snijders P; Tommasino M; Arbyn M; Franceschi S
Int J Cancer; 2014 Feb; 134(3):497-507. PubMed ID: 23568556
[TBL] [Abstract][Full Text] [Related]
25. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
26. HPV vaccine: implications for nurses and patients.
Schmidt JV
Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
[No Abstract] [Full Text] [Related]
27. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
Giuliano AR; Salmon D
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
[No Abstract] [Full Text] [Related]
28. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
29. Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region?
Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():vii-viii. PubMed ID: 24331825
[No Abstract] [Full Text] [Related]
30. AMWA position statement: cervical cancer prevention.
Devi G; Glodowski M; Shin E;
J Womens Health (Larchmt); 2009 Feb; 18(2):153. PubMed ID: 19183085
[No Abstract] [Full Text] [Related]
31. The next frontier in the battle against cervical cancer: prospects and challenges.
Syed M; Khalid U; Saleem T
J Pak Med Assoc; 2010 Apr; 60(4):328. PubMed ID: 20419986
[No Abstract] [Full Text] [Related]
32. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
33. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
34. A shorter interval between menarche and first sexual intercourse is associated with increased risk of high-grade cervical disease.
Smith JS
Evid Based Nurs; 2014 Jan; 17(1):6-7. PubMed ID: 23708400
[No Abstract] [Full Text] [Related]
35. Re: "Multiparameter calibration of a natural history model of cervical cancer".
Basu S; Galvani AP
Am J Epidemiol; 2007 Oct; 166(8):983; author reply 983-4. PubMed ID: 17728268
[No Abstract] [Full Text] [Related]
36. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.
Schiffman MH; Castle P
J Natl Cancer Inst; 2003 Mar; 95(6):E2. PubMed ID: 12644550
[No Abstract] [Full Text] [Related]
37. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX
Vaccine; 2013 Dec; 31 Suppl 5():xi-xii. PubMed ID: 24331752
[No Abstract] [Full Text] [Related]
38. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
Kjaer SK
Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
[No Abstract] [Full Text] [Related]
39. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
Steben M; Jeronimo J; Wittet S; Lamontagne DS; Ogilvie G; Jensen C; Smith J; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F183-91. PubMed ID: 23199962
[TBL] [Abstract][Full Text] [Related]
40. HPV and cervical cancer in the 2007 report.
WHO/ICO Information Centre on HPV and Cervical Cancer
Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
